SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-090302
Filing Date
2022-03-31
Accepted
2022-03-30 21:33:06
Documents
19
Period of Report
2022-03-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d338836d8k.htm   iXBRL 8-K 100155
2 EX-99.1 d338836dex991.htm EX-99.1 489141
3 EX-99.2 d338836dex992.htm EX-99.2 167826
4 EX-99.3 d338836dex993.htm EX-99.3 144174
5 EX-99.4 d338836dex994.htm EX-99.4 240132
6 EX-99.5 d338836dex995.htm EX-99.5 119676
7 EX-99.6 d338836dex996.htm EX-99.6 64040
8 EX-99.7 d338836dex997.htm EX-99.7 114590
  Complete submission text file 0001193125-22-090302.txt   1881952

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA bhc-20220330.xsd EX-101.SCH 2535
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE bhc-20220330_lab.xml EX-101.LAB 18036
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bhc-20220330_pre.xml EX-101.PRE 11327
13 EXTRACTED XBRL INSTANCE DOCUMENT d338836d8k_htm.xml XML 3449
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 22788830
SIC: 2834 Pharmaceutical Preparations